See It Work
See It Work
SYSTEM: OPERATIONAL OT/IT CONNECTORS: 150+ AUTONOMOUS OPERATION: 15+ DAYS GOVERNED AUTONOMY: ENFORCED AUDIT TRAIL: IMMUTABLE INDUSTRIES: ASSET-INTENSIVE & MISSION-CRITICAL DEPLOYMENT: 3-6 MONTHS VIA APEX CONTROL LOOPS: 3,400+ SYSTEM: OPERATIONAL OT/IT CONNECTORS: 150+ AUTONOMOUS OPERATION: 15+ DAYS GOVERNED AUTONOMY: ENFORCED AUDIT TRAIL: IMMUTABLE INDUSTRIES: ASSET-INTENSIVE & MISSION-CRITICAL DEPLOYMENT: 3-6 MONTHS VIA APEX CONTROL LOOPS: 3,400+
Available CSTR-PROCESS-OPT-AGT-001 AI Agent

CSTR Process Optimization Agent

An AI-powered productivity maximiser that continuously pushes CSTR reactor performance to extract maximum space-time yield, optimise energy efficiency, and minimise cycle times while staying within validated pharmaceutical safety limits. It eliminates the conservative manual setpoints that leave 20–30% throughput potential untapped.

ManufacturingPharmaceuticalFood & Beverage Process Optimisation

Target outcome · Achieve 20–30% throughput improvement and reduce specific energy consumption from 180+ kWh/kg toward 150 kWh/kg through continuous reactor optimisation.

Business problem

Pharmaceutical CSTR operations consistently underperform their theoretical capacity, with most reactors running at 60–75% of optimal space-time yield due to conservative manual setpoints, inefficient temperature profiles, and suboptimal residence time management. Reactors run 10–15°C below optimal conditions, reducing reaction rates by 25–40%, while manual adjustments take 15–30 minutes to respond to disturbances as optimal processing windows pass.

Read more Show less

The economic impact is substantial: 20–30% throughput opportunity costs $5–15M annually per major reactor, excess energy consumption adds $1–3M in unnecessary utility costs, and shift-to-shift variations in operating philosophy create further inconsistency. Human operators' natural risk aversion means that productivity improvements achievable within validated safety limits are routinely left unrealised.

What it does

The CSTR Process Optimisation Agent is an autonomous, productivity-focused Decision Agent that continuously pushes reactor performance to extract maximum space-time yield, optimise energy efficiency, and minimise cycle times while maintaining pharmaceutical quality standards.

Read more Show less

It uses Composite AI — combining thermodynamic optimisation, reaction kinetics modelling, and real-time process control — to reason across temperature profiles, residence times, mixing efficiency, and energy consumption simultaneously. Governed by bounded autonomy, every optimisation decision respects pharmaceutical validation boundaries and equipment protection limits, and all recommendations include projected throughput impact, energy efficiency calculations, and safety constraint validation.

Agent structure

  • Continuous multi-variable reactor optimisation (temperature, flow rate, mixing speed, residence time)
  • Space-time yield maximisation within validated operating limits
  • Specific energy consumption tracking and reduction toward 150 kWh/kg target
  • Reactor utilisation improvement from 70–80% toward 90–95%
  • Coordination with quality and equipment agents to prevent optimisation from compromising specifications or equipment integrity

What the team handles

Handles

Continuous reactor setpoint optimisation, throughput improvement recommendations, energy efficiency analysis, and multi-variable process adjustments within configured validation boundaries.

Does not handle

Quality specification overrides, equipment protection limit bypasses, or process changes outside the validated pharmaceutical operating range.

Humans retain authority over

Authority over decisions that push beyond established performance envelopes, changes to validated process boundaries, and any escalation triggered when quality or equipment agents flag risk.

Current process vs. with AI Agent

TODAY · PROCESS OPTIMISATIONREACTIVE
×
Operating temperature setpoint10–15°C below optimum to manage operator risk aversion
×
Residence time managementConservative cycles 20–30% longer than necessary
×
Energy consumption180–220 kWh/kg due to suboptimal temperature and mixing profiles
×
Throughput consistency across shiftsShift-to-shift variation in operating philosophy reduces facility output

Outcomes and measurement

Reactor throughput (space-time yield)

Baseline 60–75% of theoretical capacity
With agent 20–30% improvement through aggressive validated optimisation

Specific energy consumption

Baseline 180–220 kWh/kg
With agent 150 kWh/kg target through intelligent heating, cooling, and mixing control

Equipment utilisation

Baseline 70–80% utilisation
With agent 90–95% through optimised cycle times and reduced conservative buffers

Annual throughput opportunity cost

Baseline $5–15M per major reactor in lost productivity
With agent Systematic recovery of 20–30% of untapped capacity

*All figures are typical ranges. Achievable range depends on existing control maturity, data quality, and site-specific conditions.

Data inputs

Other

Temperature profilesflow ratesreaction progress indicatorsresidence time calculationsthroughput measurements. Ingested via XMPro Data Stream Designerwith integration to DCS systemsMES platformsand throughput measurement infrastructure

Energy monitoring

energy consumptionEnergy monitoring

*Categories only — no tag names or system-specific field references. Exact data mapping is scoped per site.

Scoping questions

Expect these questions in a first scoping conversation. They signal engineering discipline and help narrow the template to your specific site context.

  1. What are the current validated operating ranges for temperature, mixing speed, and residence time on each CSTR in scope?
  2. Which DCS or process historian systems will provide real-time reactor performance data, and what integration protocols are available?
  3. How is specific energy consumption currently tracked — is there a utility metering system with accessible data streams?
  4. What quality and equipment agents will act as constraint authorities, and how are inter-agent coordination rules configured in your MAGS team?
  5. What throughput improvement targets and payback timelines have been established for the proof-of-value engagement?

Want our AI to walk you through these scoping questions?

SPEAK WITH OUR TEAM

Get specialist advice on scoping this for your site.

Our specialists will help you understand how the CSTR Process Optimization Agent fits your operations, what data you'd need, and what a scoping engagement typically looks like.

← Browse all templates